Dabur India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for DABUR, BSE:500096 Dabur India Ltd.

Dabur India Ltd.

03 Feb 2022

535.20

0.01%

DABUR INDIA

Accumulate: Dabur India Ltd.

Prabhudas Lilladhar

recall and lineage over the years. Dabur has cut adspends to sustain margins (like other FMCG players) but that does not seem to be a sustainable trend given the pipeline of new launches in large categories. We expect near term volatility in margins although market share gains in core categories and new lunches around core infuse confidence. Dabur trades at 38.1xFY24 EPS after factoring in 18% EPS CAGR over FY22-24 with 24% ROE and 50% dividend payout. Retain accumulate with 12 month DCF based target price of Rs647 (unchanged). However, expect back ended returns given sectoral rotations,...

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

11 Nov 2021

535.20

0.01%

DABUR INDIA LTD

Hold: Dabur India Ltd.

Target

Geojit BNP Paribas

Dabur India Ltd (Dabur), a leading Indian FMCG company, is a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products. The company operates through Health Supplements, Digestives, Shampoos, Hair...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

08 Nov 2021

535.20

0.01%

Result Update:Dabur India

Buy: Dabur India Ltd.

Target

Axis Direct

Maintain BUY with revised TP of Rs. 680 (Rs. 590 earlier) and roll forward our PE multiple of 49x to Sep23 earnings.

Axis Direct upgraded Dabur India Ltd. to Buy with a price target of 630.0 on 05 Sep, 2025.

Dabur India Ltd.

03 Nov 2021

535.20

0.01%

Dabur India: Q2FY22 Result Review

Buy: Dabur India Ltd.

Target

IDBI Capital

DABUR India (DABUR) 2QFY22 result was above our estimates. DABUR continued to post strong double digit growth on a high base driven by market share gains across all key verticals; Health Care, Home Care, Personal Care and Foods. Health Care witnessed some moderation in demand especially for health supplements compared to previous quarters, but tailwinds still persists and DABUR continues to gain market share from competition. Revenue growth in HPC and Foods portfolio is tracking well; aggressive product launches and strong market share gains are healthy signs. Urban market grew at higher rate compared to rural for DABUR. Positively, international business...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

03 Nov 2021

535.20

0.01%

Dabur India

Buy: Dabur India Ltd.

Target

ICICI Securities Limited

Significant shift in consumption towards healthier, natural & Ayurveda based products would be driving growth for the company Aggressively foraying into many big categories (edible oil, carbonated drink, household insecticides, fruit drinks) and new products launches Increasing the distribution of many urban products in hinterland reach of 83,000 villages) with lower price points & different variants (honey Tasties') With normalisation of mobility, full-fledged summer season after acquisition of south & west territories is likely to drive robust volume growth...

Axis Direct upgraded Dabur India Ltd. to Buy with a price target of 630.0 on 05 Sep, 2025.

Dabur India Ltd.

02 Nov 2021

535.20

0.01%

Q2FY22 Result Update - Accumulate in Rural demand uncertainty

Accumulate: Dabur India Ltd.

Target

Prabhudas Lilladhar

Grew Rural coverage to 83.5k 18 months ahead of timeline. We upgrade Dabur from Hold to Accumulate following strong market share gains in core categories, sustained increase in direct rural reach, lesser impact of input cost inflation due to niche products and sustained innovation pipeline. Although rural demand is a bit soft, we expect it to be temporary given good monsoons and increased rural job opportunities in Infra and housing. Management maintains double digit revenue growth for FY22 and...

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

06 Aug 2021

535.20

0.01%

DABUR INDIA LTD

Hold: Dabur India Ltd.

Recommendation Target

Geojit BNP Paribas

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

04 Aug 2021

535.20

0.01%

Dabur India: Q1FY22 Result Review

Buy: Dabur India Ltd.

Recommendation Target

IDBI Capital

Market share gain across categories drive high double digit revenue growth Consolidated revenue grew 32%YoY (v/s -13%YoY in Q1FY21) driven by 35%YoY growth in India FMCG business (+34%YoY volume growth) while International business grew 28%YoY (+34% CC growth). Growth in Health Care remained strong at 30%YoY (vs 29%YoY in 1QFY21) driven by market share gains in Chyawanprash, Pudin Hara and Hajmola. Foods portfolio recorded strong business recovery (+80%YoY) driven by 85% YoY revenue growth in Beverages (Real gained 20bp market share) and 18%YoY growth in Culinary segments. Revenue from HPC grew 26% YoY driven by...

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

04 Aug 2021

535.20

0.01%

Dabur India

Buy: Dabur India Ltd.

Target

ICICI Securities Limited

Axis Direct upgraded Dabur India Ltd. to Buy with a price target of 630.0 on 05 Sep, 2025.

Dabur India Ltd.

03 Aug 2021

535.20

0.01%

Q1FY22 Result Update - Peaked out performance, cut to Hold

Hold: Dabur India Ltd.

Target

Prabhudas Lilladhar

believe that long term outlook remains positive given 1) Innovation led growth strategy, 2) Increasing share in oral care on the back of growth in herbal category 3) Innovations at low price point in beverages allowing DABUR to leverage its distribution 4) Cost saving initiatives like Project Samruddhi (savings of Rs 1.0bn in FY22) and 6) Focus on increasing rural distribution to 80k villages in 2 yrs. However recent surge in share price more than factors the positives, we therefore assign Hold rating (Under Review earlier) to the stock with TP of Rs 588. Expect near term underperformance, although long...

Axis Direct upgraded Dabur India Ltd. to Buy with a price target of 630.0 on 05 Sep, 2025.

Is Dabur India Ltd. worth buying?

670 Votes:

Buy 76.72%

Sell 12.09%

Hold 11.19%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf